Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review

 Published On: Jul, 2015 |    No of Pages: 48 |  Published By: GlobalData | Format: PDF
Request Free Sample

Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Novozymes A/S (Novozymes) is a biotech company. Its core business includes industrial enzymes, microorganisms, biopolymers and biopharmaceutical ingredients. The company develops, produces and distributes enzymes for detergent, technical, food and feed industries. It supplies a range of microorganisms for use in agriculture, industrial cleaning and wastewater treatment. Novozymes provides various biopharmaceutical ingredients for the pharmaceutical industry. The company caters products to various industries such as household care, agriculture, biopharmaceuticals, bioenergy, food and beverages, pulp and paper, leather, wastewater and textiles. It operates in various countries including Denmark, Austria, Japan, India, Sweden, Brazil, Canada, China, the UK and Spain. Novozymes is headquartered in Bagsvaerd, Denmark.

Novozymes AS Key Recent Developments

May 05, 2015: Novozymes to supply enzymes to St1 Biofuels in Finland
Apr 23, 2015: Novozymes Interim report for the first 3 months of 2015
Jan 29, 2015: India’s Punjab state plans to set up Asia's first bio-ethanol facility
Nov 18, 2013: M&G Chemicals JV to construct Chinese glycols biorefinery
Oct 09, 2013: World’s first advanced biofuels facility opens

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Novozymes A/S - Key Facts 6
Novozymes A/S - Key Employees 7
Novozymes A/S - Key Employee Biographies 8
Novozymes A/S - Major Products and Services 9
Novozymes A/S - History 10
Novozymes A/S - Company Statement 14
Novozymes A/S - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Section 2 – Company Analysis 18
Novozymes A/S - Business Description 18
Novozymes A/S - Corporate Strategy 19
Novozymes A/S - SWOT Analysis 20
SWOT Analysis - Overview 20
Novozymes A/S - Strengths 20
Strength - Leading Market Position 20
Strength - Diversified End Markets 20
Strength - Sound Operational Performance 20
Novozymes A/S - Weaknesses 21
Weakness - Customer Concentration 21
Novozymes A/S - Opportunities 22
Opportunity - Growing Demand for Industrial Enzymes 22
Opportunity - New Product Launches 22
Opportunity - Strategic Initiatives 22
Novozymes A/S - Threats 23
Threat - Intense Competition 23
Threat - Stringent Government Regulations 23
Threat - Uncertain R&D Outcomes 23
Novozymes A/S - Key Competitors 24
Section 3 – Company Financial Ratios 25
Financial Ratios - Capital Market Ratios 25
Financial Ratios - Annual Ratios 26
Performance Chart 28
Financial Performance 28
Financial Ratios - Interim Ratios 29
Financial Ratios - Ratio Charts 30
Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances 31
Novozymes A/S, Power, Deals By Year, 2009 to YTD 2015 31
Novozymes A/S, Power, Deals By Type, 2009 to YTD 2015 32
Novozymes A/S, Recent Deals Summary 33
Section 5 – Company’s Recent Developments 34
May 05, 2015: Novozymes to supply enzymes to St1 Biofuels in Finland 34
Apr 23, 2015: Novozymes Interim report for the first 3 months of 2015 35
Jan 29, 2015: India’s Punjab state plans to set up Asia's first bio-ethanol facility 36
Dec 02, 2014: New enzyme technology converts waste oils into biodiesel 37
Dec 02, 2014: Payback for biodiesel producers 38
Jul 09, 2014: Europe plants €3.7 billion in the biobased economy 39
Jul 08, 2014: Danish bio refinery receives EU funding 40
Apr 24, 2014: Novozymes announces interim report for the first 3 months of 2014 41
Feb 24, 2014: The Inter-American Development Bank and Novozymes to support the development of sustainable bioenergy solutions 42
Feb 10, 2014: Novozymes and Monsanto complete closing of The BioAg Alliance 43
Section 6 – Appendix 44
Methodology 44
Ratio Definitions 44
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables

Novozymes A/S, Key Facts 6
Novozymes A/S, Key Employees 7
Novozymes A/S, Key Employee Biographies 8
Novozymes A/S, Major Products and Services 9
Novozymes A/S, History 10
Novozymes A/S, Other Locations 15
Novozymes A/S, Subsidiaries 15
Novozymes A/S, Key Competitors 24
Novozymes A/S, Ratios based on current share price 25
Novozymes A/S, Annual Ratios 26
Novozymes A/S, Interim Ratios 29
Novozymes A/S, Power, Deals By Year, 2009 to YTD 2015 31
Novozymes A/S, Power, Deals By Type, 2009 to YTD 2015 32
Novozymes A/S, Recent Deals Summary 33
Currency Codes 44
Capital Market Ratios 44
Equity Ratios 45
Profitability Ratios 45
Cost Ratios 46
Liquidity Ratios 46
Leverage Ratios 47
Efficiency Ratios 47

List of Figures

Novozymes A/S, Performance Chart (2010 - 2014) 28
Novozymes A/S, Ratio Charts 30
Novozymes A/S, Power, Deals By Year, 2009 to YTD 2015 31
Novozymes A/S, Power, Deals by Type, 2009 to YTD 2015 32


If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.